This afternoon's spike in shares of Complete Genomics (GNOM +7.1%) may be attributable to...

|About: Complete Genomics, Inc. (GNOM)|By:, SA News Editor

This afternoon's spike in shares of Complete Genomics (GNOM +7.1%) may be attributable to remarks by CEO Cliff Reid on a recent paper that finds GNOM's whole genome sequencing service more accurate than Illumina's (ILMN +0.7%) HiSeq 2000 instrument. Reid says GNOM's sequencing produces 1/50th as many errors as ILMN's.